PLEOPHARMA
Live / Applied — New application — not yet assigned to an examiner (as of 02 Nov 2026)
What this means for you
Not registered yet, but its 02 Nov 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50194437
- Mark type
- Word mark
- Filed
- 02 Nov 2026
- Attorney of record
- Karen K. Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and management of neuropsychiatric conditions, substance use and addiction disorders, central nervous system disorders, cannabis dependence, cannabis use disorder and cannabis withdrawal syndrome; pharmaceutical preparations for the treatment and management of cannabis withdrawal symptoms; therapeutic agents targeting suppressed CB1 receptors and neurotransmitter dysregulation in the mesolimbic reward pathway.
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the fields of neuropsychiatry, neuropsychopharmacology, addiction medicine, treatment of substance use and addiction disorders; Providing scientific research information in the fields of neuropsychiatry, neuropsychopharmacology, addiction medicine, treatment of substance use and addiction disorders.
Owner
- PleoPharma, Inc., PHOENIXVILLE, PA, US
Prosecution history
- 02 Nov 2026 — APPLICATION FILING RECEIPT MAILED
- 02 Nov 2026 — NEW APPLICATION ENTERED